NovoCure (NVCR) Long-Term Debt Repayments (2018 - 2025)
NovoCure's Long-Term Debt Repayments history spans 8 years, with the latest figure at $560.9 million for Q4 2025.
- On a quarterly basis, Long-Term Debt Repayments changed N/A to $560.9 million in Q4 2025 year-over-year; TTM through Mar 2026 was $560.9 million, a 4244.03% increase, with the full-year FY2025 number at $560.9 million, up 4244.03% from a year prior.
- Long-Term Debt Repayments hit $560.9 million in Q4 2025 for NovoCure, up from $12.9 million in the prior quarter.
- Over the last five years, Long-Term Debt Repayments for NVCR hit a ceiling of $560.9 million in Q4 2025 and a floor of $3000.0 in Q2 2023.
- Historically, Long-Term Debt Repayments has averaged $47.8 million across 5 years, with a median of $7000.0 in 2021.
- Biggest five-year swings in Long-Term Debt Repayments: plummeted 100.0% in 2021 and later skyrocketed 430333.33% in 2024.
- Tracing NVCR's Long-Term Debt Repayments over 5 years: stood at $7000.0 in 2021, then changed by 0.0% to $7000.0 in 2022, then plummeted by 57.14% to $3000.0 in 2023, then skyrocketed by 430333.33% to $12.9 million in 2024, then surged by 4244.03% to $560.9 million in 2025.
- Business Quant data shows Long-Term Debt Repayments for NVCR at $560.9 million in Q4 2025, $12.9 million in Q2 2024, and $3000.0 in Q2 2023.